該雜志國際簡稱:OPEN LIFE SCI,是由出版商Walter de Gruyter GmbH出版的一本致力于發(fā)布生物學研究新成果的的專業(yè)學術期刊。該雜志以BIOLOGY研究為重點,主要發(fā)表刊登有創(chuàng)見的學術論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術影響力。
《Open Life Sciences》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱開放生命科學,本刊主要出版、報道生物學-BIOLOGY領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果,介紹該領域有關本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術信息交流,提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄,為該領域相關學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為1.7,最新CiteScore 指數(shù)為2.5。
本刊近期中國學者發(fā)表的論文主要有:
Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
Open Life Sciences (previously Central European Journal of Biology) is a fast growing peer-reviewed journal, devoted to scholarly research in all areas of life sciences, such as molecular biology, plant science, biotechnology, cell biology, biochemistry, biophysics, microbiology and virology, ecology, differentiation and development, genetics and many others. Open Life Sciences assures top quality of published data through critical peer review and editorial involvement throughout the whole publication process. Thanks to the Open Access model of publishing, it also offers unrestricted access to published articles for all users.